Fitness and type 2 diabetes mellitus
Not Applicable
- Conditions
- E11Type 2 diabetes mellitus
- Registration Number
- DRKS00022052
- Lead Sponsor
- Deutsche Sporthochschule Köln Institut für Kreislaufforschung
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 17
Inclusion Criteria
type 2 diabetes mellitus
Exclusion Criteria
insulin treatment, severe secondary complications, other chronic diseases
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iNOS (Inducible nitric oxide synthase) contents and nitrite concentration in skeletal muscle biopsies taken 6 weeks pre- / 1 week pre- and 3-4 days post-training
- Secondary Outcome Measures
Name Time Method glycemic control (HbA1c), maximal oxygen consumption (VO2peak) by spirometry 6 weeks pre-/ 1 week pre- and 3-4 days post-training
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link physical fitness to improved outcomes in type 2 diabetes mellitus (E11)?
How does the interventional approach in DRKS00022052 compare to standard-of-care therapies for T2DM in terms of efficacy and metabolic impact?
Are there specific biomarkers associated with patient response to fitness-based interventions in type 2 diabetes mellitus (E11)?
What adverse events are commonly reported in fitness intervention trials for type 2 diabetes mellitus (E11) and how are they managed?
What combination therapies or pharmaceutical approaches complement fitness interventions in managing type 2 diabetes mellitus (E11)?